Company intelligence

SNP Biopharma Consulting

Bridging Discovery and Development

Biotechnology Research

1 employees

1 public signals

Verified activity

Signals from SNP Biopharma Consulting

1 published signal

Research & Knowledge

SNP Biopharma Consulting presented Phase 3 results for plozasiran (REDEMPLO®), an siRNA targeting APOC3, at the ESC Congress 2026.

Reported by Sanjay K. Pandey, PhD

Find the companies already in motion.

Customize signals around your market, buyers, competitors, and investment thesis.

© 2026 SeedOpsCompany intelligence.

SeedOps.